Regulator authorises deuruxolitinib for adults with extensive hair loss
Study aims to advance treatment options for severe peripheral arterial disease
Pharmaceutical projects to tackle the threat of antimicrobial resistance (AMR) have declined by over a third (35%) in […]
A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous […]
Policies encouraging physical activity have failed to make a tangible difference over the past two decades, according to […]
AbstractObjectiveTo evaluate whether prenatal exposure to specific antiseizure drugs increases the risk of neurodevelopmental disorders in children.DesignPopulation based […]
A new non-hormonal daily pill for menopausal hot flushes and night sweats can now be prescribed on the […]
MPs have rejected a call from the House of Lords to ban the use of social media for […]
What you need to knowOffer four classes of medicine (angiotensin converting enzyme inhibitors, beta blockers, mineralocorticoid receptor antagonists, […]
Scientists and physicians around the world were horrified when the US Environmental Protection Agency (EPA) announced its plan […]